The impact of COVID-19 on dermatologicals in 2020 was fairly limited, with consumers typically only purchasing products in this category when needed. However, some dermatological products such as germicides/antiseptics benefited from initial stockpiling as consumers prepared for lockdowns and potential two week quarantines.
Antiparasitics/lice (head and body) treatments current value sales declined in 2020. While current value growth is expected to pick up slightly over the forecast period, the development of the category will continue to be constrained by falling birth rates in Canada as head lice infestations are most common among school-aged children.
McNeil Consumer Healthcare remains the overall leader in dermatologicals in value terms, followed by Bayer. Both companies maintain wide portfolios and hold strong positions in a number of categories – McNeil in topical allergy remedies/antihistamines and hair loss treatments, for example, and Bayer in topical and vaginal antifungals.
Haemorrhoid treatments continues to post strong growth and is projected to remain the most dynamic performer over the forecast period. The Canadian Digestive Health Foundation estimates that approximately 60-70% of Canadians will suffer from haemorrhoids at some point in their lives.
Topical germicidals/antiseptics looks set to remain by far the largest category within dermatologicals in value terms over the forecast period. Current value growth is expected to be relatively modest, however, while retail volume sales are projected to decline slightly.
The scope for innovation in dermatologicals is limited by maturity. As a result, manufacturers mainly rely on variations in product or packaging formats to generate consumer interest and differentiate their brands.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Medicated Skin Care industry in Canada with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Medicated Skin Care industry in Canada, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Medicated Skin Care research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page